Quantcast

Latest epileptic seizure Stories

2014-04-30 23:16:18

A&A Packaging comments on a Canadian mother’s story of how medical marijuana saved her once terminally ill daughter's life, and cured her from having 100 seizures a day. Seattle, WA (PRWEB) April 30, 2014 Only until recently has medical marijuana received its deserved accolades by the mainstream media as a miracle drug; however, many in the medical industry are still leaving pot on the back-burner....until NOW. A Canadian mother named Sarah Wilkinson has tangible claims about...

2014-04-30 08:32:32

ATLANTA, April 30, 2014 /PRNewswire/ -- Today, the U.S. Department of Veterans Affairs' Epilepsy Centers of Excellence (ECoE), biopharmaceutical company UCB, and health data sharing network PatientsLikeMe(®) presented the results of the Policy for Optimal Epilepsy Management (POEM) study at the 66(th) Annual Meeting of the American Academy of Neurology in Philadelphia, Pa. This first-time, real-world study of an online health management platform demonstrated statistically significant...

2014-04-29 16:59:13

A graduate student in Semel Institute for Neuroscience and Human Behavior, and two of his undergraduate trainees, were selected by the Council on Undergraduate Research to present their original research on Capitol Hill in Washington, D.C., on Tuesday. Wesley Kerr, whose graduate studies will be completed in the UCLA Department of Biomathematics, and his trainees, Akash Patel and Sarah Barritt, will present their poster entitled "Computer-Aided Diagnosis of Epilepsy Using Clinical...

2014-04-29 16:31:05

USL261 Demonstrates Promising PK, PD and Safety Profiles in Patients with Epilepsy PHILADELPHIA, April 29, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that Phase I data for USL261 (investigational intranasal midazolam) in patients with epilepsy were presented at the 66(th)( )Annual American Academy of Neurology (AAN) meeting in Philadelphia. The results demonstrated that USL261 at a single dose of up to 7.5 mg was rapidly absorbed and exhibited a...

2014-04-23 12:30:45

Quest Diagnostics' specialty neurology business unveils 10 new epilepsy diagnostic services, including industry's first clinical multi-analyte test for autoimmune epilepsy MADISON, N.J., April 23, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a suite of new testing services from its Athena Diagnostics specialty neurology business designed to help physicians more reliably and quickly diagnose the...

2014-04-23 09:48:55

Rush University Medical Center is the first in the country to use the device along with a unique electrode placement planning system A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the...

2014-04-23 09:42:49

Although some studies have suggested that the drug lorazepam may be more effective or safer than the drug diazepam in treating a type of epileptic seizures among children, a randomized trial finds that lorazepam is not better at stopping seizures compared to diazepam, according to a study in the April 23/30 issue of JAMA, a neurology theme issue. Status epilepticus is a prolonged epileptic seizure or seizures that occurs approximately 10,000 times in children annually in the United States....

2014-04-21 12:27:11

Upsher-Smith-sponsored data to include the first presentation of pooled Phase 1 data on the adverse event profile of USL255 (Qudexy(TM) XR (topiramate) extended-release capsules) MAPLE GROVE, Minn., April 21, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), will highlight new pooled phase 1 data from studies in healthy adults comparing the adverse event profile of USL255 (Qudexy(TM) XR) with immediate-release topiramate in a poster presentation at the 66(th) Annual Meeting...

2014-04-16 23:17:43

Dr. Nathan R. Selden of Oregon Health and Science University hosts the 13th National Conference on Hydrocephalus, July 9-11, 2014, sponsored by the Hydrocephalus Association. Bethesda, MD (PRWEB) April 16, 2014 Leading medical professionals, researchers, patients and their families will gather in downtown Portland for the 13th National Conference on Hydrocephalus, hosted by the Hydrocephalus Association (HA). The biennial conference provides tools and personal connections to address the...

2014-04-14 23:04:09

Dayton Children’s Hospital neurology division earned designation by the National Association of Epilepsy Centers as a Level 3 center for the treatment of complex pediatric epilepsy. Receiving the designation certifies that Dayton Children’s has the professional expertise and facilities to provide the highest level medical evaluation and treatment for patients with complex epilepsy. Dayton, OHIO (PRWEB) April 14, 2014 Dayton Children’s Hospital neurology division earned designation...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related